SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-018017
Filing Date
2023-05-05
Accepted
2023-05-04 18:06:50
Documents
71
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rare-20230331.htm   iXBRL 10-Q 2935806
2 EX-10.1 rare-ex10_1.htm EX-10 108730
3 EX-10.2 rare-ex10_2.htm EX-10 75070
4 EX-10.3 rare-ex10_3.htm EX-10 35571
5 EX-31.1 rare-ex31_1.htm EX-31 19786
6 EX-32.1 rare-ex32_1.htm EX-32 9941
7 GRAPHIC img215925227_0.jpg GRAPHIC 170282
  Complete submission text file 0000950170-23-018017.txt   10093394

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rare-20230331_cal.xml EX-101.CAL 47155
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rare-20230331_pre.xml EX-101.PRE 294456
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rare-20230331_def.xml EX-101.DEF 173329
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rare-20230331.xsd EX-101.SCH 59995
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rare-20230331_lab.xml EX-101.LAB 400896
65 EXTRACTED XBRL INSTANCE DOCUMENT rare-20230331_htm.xml XML 1879268
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36276 | Film No.: 23890460
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences